New bill to change Patent Act surfaces

As Parliament looms, a new battle over Canada's Access to Medicines Regime is ignited.

Ally Foster
Published: Wednesday, 08/15/2012 12:00 am EDT

With less than five weeks to go before Parliament resumes, players from pharmaceutical giants to grandmothers are already lobbying hard on a new bill that would make it easier for generic drug manufacturers to produce name-brand medicine for developing countries.

If you are already a subscriber

Subscribe to Embassy

Subscribe to the print and electronic editions and get instant access to Embassy online.

Quick purchase

Purchase this week's edition of Embassy in electronic format (PDF) for $4.00

Sign up for a free trial

For access to the website.

This Week's Issue
policy briefings